-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$36.1189.16% Upside
Syndax Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. has been rated by research analysts at UBS, Citigroup, Bank of America Securities, Barclays, Jefferies, Stifel Nicolaus in the past 90 days.